# Clinical trials recruiting in New York: 4,830 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 4,830 trials recruiting or not yet recruiting with a site in New York, as read on November 19, 2026.

## The full list

Clinical trials recruiting in New York: 4,830 rows for $128.30, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 86 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/new-york

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 4,830
- Recruiting or not yet: 4,830
- Read on: November 19, 2026

## Trials

The 25 newest of 4,830, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07945873 | Primary Sclerosing Cholangitis After Liver Transplant With Oral Vancomycin | Sponsor not shown (see the record) | Phase 1 | Not yet recruiting | Primary Sclerosing Cholangitis, Liver Transplant Disorder | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945873) |
| November 18, 2026 | NCT07944326 | Cardiovascular and Renal Protection With SGLT Inhibition in Kidney Transplant Recipients: The RENAISSANCE Trial | University of British Columbia | Phase 3 | Not yet recruiting | Kidney Transplant Recipient | 900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944326) |
| November 17, 2026 | NCT07943624 | Is Restrictive Eating Behavior in Anorexia Nervosa Short-sighted? An Experimental Investigation | New York State Psychiatric Institute | Not applicable | Not yet recruiting | Anorexia Nervosa | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07943624) |
| November 17, 2026 | NCT07942324 | Conversational Memory in Aging and AD | New York University | Not applicable | Not yet recruiting | Alzheimer Dementia (AD), Mild Cognitive Impairment (MCI) Amnestic | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942324) |
| November 17, 2026 | NCT07941492 | A Trial of FHD-286 Plus Mosunetuzumab in Previously Treated Follicular Lymphoma | Weill Medical College of Cornell University | Phase 1 | Not yet recruiting | Follicular Lymphoma | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941492) |
| November 16, 2026 | NCT07939529 | People With Active Viremia Treated With Lenacapavir and Long-Acting Cabotegravir for Effectiveness | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | Not yet recruiting | HIV Viremia | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939529) |
| November 13, 2026 | NCT07936266 | Asciminib and Inotuzumab Ozogamicin for Relapsed or Refractory Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (R/R... | Sponsor not shown (see the record) | Phase 1 | Recruiting | B-cell Acute Lymphoblastic Leukemia (B-ALL) | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07936266) |
| November 13, 2026 | NCT07936227 | Effect of Sirolimus on Oocyte Quality in Women Undergoing IVF | Center for Human Reproduction | Phase 4 | Recruiting | Oocytes, Oocyte Competence, Oocyte Retrieval for IVF, IVF, Infertility | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07936227) |
| November 13, 2026 | NCT07935603 | Aural Rehab for Adult CI Outcomes | NYU Langone Health | Not applicable | Not yet recruiting | Bilateral Hearing Loss | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935603) |
| November 13, 2026 | NCT07935356 | A Phase 3 Evaluation of Sutacimig in Glanzmann Thrombasthenia | Sponsor not shown (see the record) | Phase 3 | Recruiting | Thrombasthenia | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935356) |
| November 12, 2026 | NCT07934082 | Trauma Adapted Yoga for Adolescents and Young Adults in Psychiatric Outpatient Treatment | State University of New York - Upstate Medical University | Not applicable | Recruiting | Psychiatric Disorders, Emotional Dysregulation | 143 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934082) |
| November 12, 2026 | NCT07933094 | Combined TECAR/EMS Therapy vs. Standard Manual Therapy for Endometriosis Pelvic Pain | SWIMS America Corp. | Not applicable | Recruiting | Endometriosis, Pelvic Pain | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933094) |
| November 12, 2026 | NCT07931703 | Safety, Tolerability and Efficacy of RGH-202 in Social Anxiety Disorder (STAGE) | Gedeon Richter Plc. | Phase 2 | Not yet recruiting | Social Anxiety Disorder | 156 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931703) |
| November 12, 2026 | NCT07931690 | IMPACT-Ready Study | Sponsor not shown (see the record) | Observational | Not yet recruiting | Autism Spectrum Disorder, Neurodevelopmental Disorders | 1,250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931690) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 12, 2026 | NCT07931547 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes, Chronic Kidney Disease | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931547) |
| November 12, 2026 | NCT07930884 | Continuous Glucose Monitoring Parameter and Oral Glucose Tolerance Testing (OGTT) Parameters in Children and Young Adults With Cystic... | Northwell Health | Not applicable | Recruiting | Cystic Fibrosis Related Diabetes, CGM | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930884) |
| November 10, 2026 | NCT07928258 | A Study of LY4336619 in Adult Participants With Advanced Solid Tumors | Eli Lilly and Company | Phase 1 | Not yet recruiting | Endometrial Neoplasms, Ovarian Neoplasms, Neoplasms, Germ Cell and Embryonal, Carcinoma, Non-Small-Cell Lung, Stomach... | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928258) |
| November 10, 2026 | NCT07928245 | A Study of Brenipatide in Participants With Major Depressive Disorder | Eli Lilly and Company | Phase 2 | Not yet recruiting | Major Depressive Disorder | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928245) |
| November 10, 2026 | NCT07927998 | A Study of Retifanlimab After Chemoradiation in People With Anal Cancer | Memorial Sloan Kettering Cancer Center | Phase 2 | Recruiting | Anal Squamous Cell Carcinoma, Anal Cancer, Anal Carcinoma | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927998) |
| November 10, 2026 | NCT07927673 | Decentralized, Status Neutral, Stakeholder-engaged, Post-incarceration Intervention for People Living With and at Risk for HIV | Montefiore Medical Center | Not applicable | Not yet recruiting | Substance Use Disorder (SUD), HIV (Human Immunodeficiency Virus), Viral Suppression of HIV Infection | 420 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927673) |
| November 10, 2026 | NCT07927595 | Observational Connectomics in Adults Undergoing Resection of WHO II-IV Glioma | Northwell Health | Observational | Recruiting | Glioma, Glioma (Any Grade) in the Brain, Glioblastom WHO Grade 4, Glioblastoma, Glioblastoma (GBM), Grade III... | 125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927595) |
| November 10, 2026 | NCT07927504 | Relapse Prevention and Changing Habits in Anorexia Nervosa 2.0 | New York State Psychiatric Institute | Not applicable | Not yet recruiting | Anorexia Nervosa, Atypical Anorexia Nervosa | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927504) |
| November 10, 2026 | NCT07927491 | Surgical Window Study of CM93 in Subjects With Recurrent Glioblastoma (rGBM) | NYU Langone Health | Phase 1 | Not yet recruiting | Recurrent Glioblastoma With EGFR Mutation | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927491) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Memorial Sloan Kettering Cancer Center | New York | 499 |
| NYU Langone Health | New York | 339 |
| Icahn School of Medicine at Mount Sinai | New York | 239 |
| Montefiore Medical Center | The Bronx | 187 |
| Columbia University Irving Medical Center | New York | 179 |
| Roswell Park Cancer Institute | Buffalo | 178 |
| University of Rochester | Rochester | 172 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | 150 |
| Weill Cornell Medicine | New York | 137 |
| University of Rochester Medical Center | Rochester | 118 |
| Columbia University Medical Center | New York | 116 |
| Mount Sinai Hospital | New York | 114 |
| Columbia University | New York | 112 |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison | 95 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Uniondale | 83 |
| Northwell Health | Lake Success | 83 |
| Memorial Sloan Kettering Westchester | Harrison | 78 |
| Montefiore Medical Center - Moses Campus | The Bronx | 77 |
| Stony Brook University Medical Center | Stony Brook | 73 |
| Albany Medical Center | Albany | 71 |
| Memorial Sloan Kettering Nassau | Rockville Centre | 71 |
| Laura and Isaac Perlmutter Cancer Center at NYU Langone | New York | 69 |
| Memorial Sloan Kettering Commack | Commack | 66 |
| Hospital for Special Surgery | New York | 61 |
| State University of New York Upstate Medical University | Syracuse | 60 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 37 |
| Phase 1 | 448 |
| Phase 1/2 | 378 |
| Phase 2 | 820 |
| Phase 2/3 | 99 |
| Phase 3 | 848 |
| Phase 4 | 161 |
| Not applicable | 1,299 |
| Observational | 740 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Breast Neoplasms | 196 |
| Carcinoma, Non-Small-Cell Lung | 189 |
| Neoplasms | 151 |
| Prostatic Neoplasms | 134 |
| Neoplasm Metastasis | 115 |
| Colorectal Neoplasms | 109 |
| Lung Neoplasms | 101 |
| Ovarian Neoplasms | 96 |
| Obesity | 85 |
| Multiple Myeloma | 81 |
| Recurrence | 81 |
| Leukemia, Myeloid, Acute | 79 |
| Endometrial Neoplasms | 76 |
| Pancreatic Neoplasms | 74 |
| Depression | 69 |
| Squamous Cell Carcinoma of Head and Neck | 61 |
| Heart Failure | 60 |
| Melanoma | 57 |
| Triple Negative Breast Neoplasms | 50 |
| Overweight | 47 |
| Lymphoma | 47 |
| Stomach Neoplasms | 47 |
| Stroke | 46 |
| Depressive Disorder, Major | 46 |
| Urinary Bladder Neoplasms | 46 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Memorial Sloan Kettering Cancer Center | 313 |
| NYU Langone Health | 235 |
| Columbia University | 174 |
| Icahn School of Medicine at Mount Sinai | 154 |
| Weill Medical College of Cornell University | 148 |
| University of Rochester | 97 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 94 |
| National Cancer Institute (NCI) | 84 |
| Northwell Health | 81 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 70 |
| Montefiore Medical Center | 64 |
| Roswell Park Cancer Institute | 63 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 59 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 55 |
| State University of New York at Buffalo | 49 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 48 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 48 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 41 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 40 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 34 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 33 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 33 |
| Hospital for Special Surgery, New York | 32 |
| VA Office of Research and Development | 32 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 31 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Textile manufacturers in New York, New York](https://specstream.ai/data/businesses/textile-manufacturers/new-york-new-york-united-states)
- [Business management services in New York, New York](https://specstream.ai/data/businesses/business-management-services/new-york-new-york-united-states)
- [Exporters in New York, New York](https://specstream.ai/data/businesses/exporters/new-york-new-york-united-states)
- [Marketing agencies in New York, New York](https://specstream.ai/data/businesses/marketing-agencies/new-york-new-york-united-states)
- [Real estate law firms in New York, New York](https://specstream.ai/data/businesses/real-estate-law-firms/new-york-new-york-united-states)
- [Alternative medicine clinics in New York, New York](https://specstream.ai/data/businesses/alternative-medicine-clinics/new-york-new-york-united-states)
